drugset
drugset / Trial / NCT04294654

Vortioxetine in Patients With Depression and Early Dementia

NCT04294654 ↗

Phase 4 Completed 82 enrolled H. Lundbeck A/S ICON plc · collab
NaSingle-groupOpen-labelTreatment

Summary

This study evaluates the effectiveness of vortioxetine on depressive symptoms in patients with depression and early dementia

Timeline

Start
2020-02-28
Primary completion
2022-07-06
Completion
2022-07-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Vortioxetine Unknown 5 mg Oral
Subject Vortioxetine Unknown 10 mg Oral
Subject Vortioxetine Unknown 20 mg Oral

Indications

dementia major depressive disorder